Group 1 - Digital Bridge Group's share price surged nearly 10% following news of a buyout by SoftBank Group, indicating strong market interest [1][2] - The acquisition deal has an enterprise value of approximately $4 billion, with SoftBank agreeing to pay $16 per share in cash for DigitalBridge [2][6] - DigitalBridge operates in the digital infrastructure sector, which is experiencing high demand due to the needs of artificial intelligence, making it a strategic investment opportunity [4][5] Group 2 - SoftBank's CEO Masayoshi Son emphasized that the acquisition aims to strengthen the foundation for next-generation AI data centers and advance their vision of becoming a leading Artificial Super Intelligence platform provider [5] - DigitalBridge's current market cap is $2.5 billion, with its stock closing at $15.26, below the acquisition price, reflecting some skepticism among investors regarding the deal's completion [6][8] - The deal is considered smaller in scale compared to SoftBank's previous investments, such as WeWork, and is viewed positively due to DigitalBridge's reliable profitability and strong market position [7][8]

Core Insights - Praxis Precision Medicines received Breakthrough Therapy Designation (BTD) from the FDA for its experimental tremor treatment, ulixacaltamide, leading to a 13.25% increase in stock price [1][5] Company Overview - Praxis specializes in developing therapies for neurological disorders using genetic insights [3] - The company plans to submit a New Drug Application for ulixacaltamide in early 2026 [4] Clinical Development - The BTD was granted based on positive results from two recent phase 3 studies, which aim to accelerate the regulatory review process [4] - The CEO of Praxis highlighted the importance of the BTD in advancing the treatment to patients more quickly [4][7] Market Context - There is a significant unmet need for treatments for essential tremor, affecting approximately 7 million people in the U.S. [6] - Current treatment options for essential tremor are often ineffective and poorly tolerated [6]

Core Insights - Medtronic is being evaluated as a potential significant opportunity within the medical device sector, highlighting its strengths, challenges, and future potential [1] Group 1: Company Overview - Medtronic is featured in a discussion that aims to provide insights into its market trends and investment opportunities [1] Group 2: Analyst Perspectives - The analysis includes contributions from expert analysts who break down the company's performance and outlook [1]

Core Insights - MARA Holdings has reported significant financial growth, with a 92% year-over-year revenue increase to $252.4 million and a net income of $123.1 million in Q3 2025, compared to a net loss of $124.8 million in Q3 2024 [1][2]. Financial Performance - The revenue increase was primarily driven by an 88% rise in the average Bitcoin price, contributing $113.3 million to the revenue [4]. - MARA holds 53,250 BTC, valued at approximately $4.7 billion as of December 25 [4]. - Despite the positive financial results, MARA's share price has decreased by 49% over the last year, while Bitcoin has lost 12% [6]. Business Model and Strategy - MARA is heavily reliant on Bitcoin mining, which is a competitive and volatile industry, making it challenging to maintain profits [4]. - To diversify its revenue streams, MARA plans to leverage its data center infrastructure for potential sales to AI companies, although no deals have been secured yet [5].

A major change is on the way at Berkshire Hathaway; will it still be the same company it was when Warren Buffett was CEO?Warren Buffett is known as the Oracle of Omaha due to his investment success at the helm of Berkshire Hathaway (BRK.A +0.53%)(BRK.B +0.51%). The stock has created many millionaires under Buffett's watch, as it has wildly outperformed the broader market.However, Buffett is handing the reins of CEO to top lieutenant Greg Abel at the start of 2026. Is Berkshire Hathaway still worth buying?Wh ...

Today, Dec. 29, 2025, UiPath continues its upward trajectory as Morgan Stanley analysts up their price target.NYSE : PATHUiPathToday's Change( -0.09 %) $ -0.01Current Price$ 16.82Key Data PointsMarket Cap$9.0BDay's Range$ 16.34 - $ 17.3652wk Range$ 9.38 - $ 19.84Volume1.6MAvg Vol27MGross Margin83.16 %UiPath (PATH 0.09%), closed Monday at $16.85, edging up 0.06%. The end-to-end automation platform provider is robotic process automation solutions with AI technology. Trading volume reached 31.3 million shares, ...

Carvana is seeing impressive growth rates in its business. But has the stock's rise gotten out of hand?Carvana (CVNA 1.20%) has been one of the market's biggest winners in 2025, with shares more than doubling year to date. A company that once appeared to be a risky leverage story is now posting record volumes and substantial profits.But Carvana's improving business fundamentals don't automatically make the stock a buy today. The business, which operates a leading e-commerce platform for buying and selling u ...

In the remaing days of 2025, silver and gold stocks lost some sheen in investors' eyes.It's all but a certainty that First Majestic (AG 4.13%) shareholders will look back on 2025 fondly. Before today's trading session began, First Majestic stock had soared more than 217% since the start of the year. With silver prices falling today, though, First Majestic stock appeared a little less alluring.Shares of First Majestic fell 4.1% today, paring back an earlier decline of 6.9%. The silver rally hit the pause but ...

Alphabet could be a huge AI growth story over the coming years.While Alphabet (GOOGL +0.01%) (GOOG 0.18%) has been the best performer among the so-called "Magnificent Seven" stocks this year, it still may be one of the most underrated artificial intelligence (AI) stocks around and has one of the best growth stories both next year and over the long term.Let's look at why Alphabet is a stock you'll want to invest in.Controlling the entire tech stackWhen OpenAI introduced AI chatbots to the masses, Alphabet's ...

These days, we're hearing a lot about the many benefits of Roth accounts. However, they're not the best choice for every investor.In this podcast, Motley Fool retirement expert Robert Brokamp speaks with Megan Brinsfield, CFP, CPA, president of Motley Fool Wealth Management (a sister company of The Motley Fool), about when the advice to Roth goes wrong.Also in this episode:The Fed lowers interest rates, sending value and small-cap stocks soaring.Request your required minimum distributions at least a few day ...